REATA PHARMACEUTICALS INC Annual Interest Expense in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Reata Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from 2017 to 2022.
  • Reata Pharmaceuticals Inc Interest Expense for the quarter ending June 30, 2023 was $1.31M.
  • Reata Pharmaceuticals Inc annual Interest Expense for 2022 was $0.000, a 100% decline from 2021.
  • Reata Pharmaceuticals Inc annual Interest Expense for 2021 was $6.56M, a 55.9% decline from 2020.
  • Reata Pharmaceuticals Inc annual Interest Expense for 2020 was $14.9M, a 33% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 -$6.56M -100% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-24
2021 $6.56M -$8.33M -55.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
2020 $14.9M +$3.7M +33% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 $11.2M +$5.02M +81.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $6.18M +$4.72M +325% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $1.45M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.